Evidence map›Paper›PMID 42443975›Full record

ArticleJournal of health, population, and nutrition2026

Ultra-processed food and risk of cholecystitis and cholelithiasis: a prospective cohort study.

Peiyi Zheng, Feifan Wang, Kaiyang Zhang, Jiayi Qian, Qiaoqiao Fang, Jing Guo, Jiayu Li, Ding Ye, Yingying Mao, Xiaohui Sun

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peiyi Zheng *The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310053, China.
Feifan Wang *The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310053, China.
Kaiyang ZhangThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310053, China.
Jiayi QianThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310053, China.
Qiaoqiao FangThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, 310053, China.
Jing GuoDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Jiayu LiDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Ding YeDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Yingying MaoDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China. myy@zcmu.edu.cn.
Xiaohui SunDepartment of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, 310053, China. sxh@zcmu.edu.cn.

Funding

Medical Health Science and Technology Project of Zhejiang Provincial Health Commission 2025KY091, 2024KY1192, 2023KY602Natural Science Foundation of Zhejiang Province LMS25H260003, QN25H260010Research Project of Zhejiang Chinese Medical University 2023JKZKTS15, 2022RCZXZK04Zhejiang Province Traditional Chinese Medicine Science and Technology Plan Project 2026ZL0271, 2024ZF060
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe global rise in ultra-processed food (UPF) consumption has been linked to several chronic diseases. However, its association with cholecystitis and cholelithiasis remains underexplored.

methodsThis prospective cohort study included 154,376 UK Biobank participants. UPF consumption (assessed as percentage of total food weight, g/day) was categorized by the NOVA classification using Oxford WebQ-based 24-hour dietary assessments. Cox proportional hazards models were performed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident cholecystitis and cholelithiasis risk with the adjustments for demographics, lifestyle factors, nutrients, and comorbidities. Restricted cubic splines analyses were used to evaluate dose-response relationships.

resultsDuring a median follow-up of 13.2 years, higher UPF intake was associated with increased risks of cholecystitis and cholelithiasis. Participants in the highest quartile of UPF consumption (Q4) had higher risks of cholecystitis (HR:1.20, 95% CI: 1.07-1.34, P = 0.001) and cholelithiasis (HR:1.15, 95% CI: 1.05-1.25, P = 0.002), compared with the lowest quartile. Sensitivity analyses confirmed the robustness of these findings. Nonlinear relationships were observed for both diseases, with risk increasing beyond specific UPF consumption thresholds (27% of total food weight for cholecystitis and 16% for cholelithiasis). Additionally, subgroup analyses revealed inverse associations of breakfast cereals with both cholelithiasis and cholecystitis, and of ultra-processed breads with cholelithiasis, whereas snacks and desserts were positively associated with cholelithiasis risk.

conclusionsHigher total UPF consumption was independently associated with elevated risks of cholecystitis and cholelithiasis, although inverse associations were observed for certain subgroups such as breakfast cereals and ultra-processed breads. However, reducing snacks and desserts may help lower biliary disease risk, but further studies are needed to clarify the role of specific UPF subgroups.

Indexed as

CholecystitisCholelithiasisDietFast FoodsAdultAgedFemaleHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk FactorsUnited KingdomBiliary diseaseFood subtypesNOVA classificationUltra-processed food

Identifiers

PMID42443975
PMCPMC13374153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.